stock
LAB · STANDARD BIOTOOLS INC.
What STANDARD BIOTOOLS INC. reports to the SEC, read from its filings.
Open in the appPrice
The live LAB price and today's change.
Sign in to see thisChart
Thirty days of daily bars, with signal levels drawn on them.
Sign in to see thisSignals
The latest signal group Nakagai's scanner recorded on LAB.
Sign in to see thisOptions positioning
Gamma exposure levels from the options market.
Sign in to see thisTechnicals
Trend, momentum and volatility gauges per timeframe.
Sign in to see thisWhat it is
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Filer (SEC EDGAR)
- EDGAR filing index
- Shares outstanding
- 392,578,808 as of 2026-08-03 (XBRL frame CY2026Q2I)
Key stats
Valuation
- P/E
- Locked
- P/S
- Locked
- P/B
- Locked
- Enterprise value
- Locked
- EV/EBIT
- Locked
- FCF yield
- Locked
Margins
- Gross
- 50.5%
- Operating
- -112.8%
- Net
- 100.4%
Returns
- ROE
- 15.7%
- ROA
- 13.5%
Health
- Current ratio
- 9.1x
- Debt/equity
- —
Deep value
- NCAV
- $429.62M
- NCAV per share
- $1.09
- Price/NCAV
- Locked
- NNWC
- $203.14M
- NNWC per share
- $0.52
- Price/NNWC
- Locked
Valuation and the price multiples are built on the live price. Trailing twelve months to 2026-06-30; balance sheet at 2026-06-30.
Sign in to see thisDebt is long-term debt and its current portion. Commercial paper and short-term borrowings are not counted.
Results
| Period end | Revenue | Gross profit | Operating income | Net income | Filing |
|---|---|---|---|---|---|
| 2026-06-30 | $20.10M | $10.54M | -$25.39M | -$26.76M | 10-Q filed 2026-08-05 |
| 2026-03-31 | $21.15M | $11.31M | -$12.50M | $127.07M | 10-Q filed 2026-08-05 Assembled from more than one filing; the filing above is only the newest of them. |
| 2025-12-31 | $23.80M | $11.38M | -$24.64M | $19.28M | DEF 14A filed 2026-04-27 Derived: the full year minus the first three quarters, not a figure this filer reported as a quarter. Assembled from more than one filing; the filing above is only the newest of them. |
| 2025-09-30 | $19.55M | $9.48M | -$32.94M | -$34.69M | 10-Q filed 2025-11-04 |
| 2025-06-30 | $21.76M | $10.63M | -$25.70M | -$33.46M | 10-Q filed 2026-08-05 |
| 2025-03-31 | $20.22M | $11.05M | -$26.97M | -$26.03M | 10-Q filed 2026-08-05 Assembled from more than one filing; the filing above is only the newest of them. |
| 2024-12-31 | $890,000 | -$1.80M | -$10.34M | -$34.07M | DEF 14A filed 2026-04-27 Derived: the full year minus the first three quarters, not a figure this filer reported as a quarter. Assembled from more than one filing; the filing above is only the newest of them. |
| 2024-09-30 | $22.09M | $12.13M | -$26.70M | -$26.94M | 10-Q filed 2025-11-04 |
- Assets
- $627.22M
- Equity
- $539.97M
Balance as of 2026-06-30.
Ten years
| Fiscal year end | Revenue | Operating income | Net income | Free cash flow |
|---|---|---|---|---|
| 2025-12-31 | $85.33M | -$110.25M | -$74.90M | -$82.65M |
| 2024-12-31 | $91.01M | -$127.48M | -$138.88M | -$151.81M |
| 2023-12-31 | $106.34M | -$76.60M | -$74.66M | -$46.12M |
| 2022-12-31 | $97.95M | -$116.20M | -$190.10M | -$93.19M |
| 2021-12-31 | $130.58M | -$67.46M | -$59.24M | -$57.33M |
| 2020-12-31 | $138.14M | -$51.04M | -$53.02M | -$28.13M |
| 2019-12-31 | $117.24M | -$51.84M | -$64.79M | -$37.74M |
| 2018-12-31 | $112.96M | -$48.16M | -$59.01M | -$25.57M |
| 2017-12-31 | $101.94M | -$58.36M | -$60.53M | -$25.66M |
| 2016-12-31 | $104.45M | -$73.19M | -$75.98M | -$44.20M |
Company filings
events
Regulation FD disclosure
Regulation FD disclosureOct 58-KMaterial agreement, Agreement ended, Regulation FD disclosure
Material agreementAgreement endedRegulation FD disclosureSep 308-KResults, Regulation FD disclosure
ResultsRegulation FD disclosureAug 58-K8-K
Jul 298-K/AMaterial agreement, Regulation FD disclosure
Material agreementRegulation FD disclosureJul 288-KListing standard notice
Listing standard noticeJul 248-K
5% owners ()
MAK CAPITAL ONE LLC
Stake update
LONG FOCUS CAPITAL MANAGEMENT, LLC
Passive stake
BlackRock, Inc.
Stake update
VIKING GLOBAL INVESTORS LP
Activist stake
Casdin Capital, LLC
Stake update
Insiders, politicians and funds
Insider trades, last 90 days
No insider buys or sales filed in the last 90 days.
Politician trades, last 90 days
No politician trades filed in the last 90 days.
Funds
- Viking Global
Period Tue 30 Jun 2026
0.1%Same - Point72
Period Tue 30 Jun 2026
0.0%Added
News
Stories that named LAB, and the market events around them.
Sign in to see thisBoard
Recent signals
Signals open up here once a member has posted about LAB.
Signals are informational.
Posts · 0
No posts yet.
nakagai
Signals on LAB come from a rule, not a model.
Nakagai’s scanner records a signal the moment a strategy’s rule matches on the bars. Members read those signals on their own desk, where an agent journals the tape and briefs them in plain English.
Members post on the LAB board